Inhaled PLGA Particles of Prostaglandin E<sub>1</sub> Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency
Vivek Gupta(Indian Institute of Technology Tirupati), Fakhrul Ahsan(VA Northern California Health Care System), Eva Nozik‐Grayck(University of Colorado System), Imam H. Shaik, Reza Mehvar(Texas Tech University), Masahiko Oka(University of South Alabama), Nilesh Gupta(Texas Tech University), Masanobu Komatsu(Johns Hopkins University), Ivan F. McMurtry(University of South Alabama)
Cited by 29
Related Papers
Dextrans for targeted and sustained delivery of therapeutic and imaging agents
|Journal of Controlled Release|2000|426
Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls
|Journal of Pharmaceutical Sciences|1989|394
TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
|Blood|2019|313
Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
|PubMed|2001|184
Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples
|Analytical and Bioanalytical Chemistry|2006|129